Silver Book Fact

According to the National Institutes of Health, use of the clot-busting drug t-PA saves $4,400 per patient in hospitalization and nursing home costs.

Houston K. Innovative Drugs Cost Patients Less in the Long Run. Chicago Sun Times. 30-Jul-2004

Reference

Title
Innovative Drugs Cost Patients Less in the Long Run
Publication
Chicago Sun Times
Publication Date
30-Jul-2004
Authors
Houston K

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Increased use of a blood-thinning drug prevents 40,000 strokes every year in the U.S.  
  • Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • Use of antihypertensive therapies avoided an estimated $10.7 billion in 2002 direct medical costs as a result of fewer strokes. They also avoided an estimated $5.8 billion in 2002…  
  • From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states